# The ASTERS Study: Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome (ARDS)

> **NCT03654352** · — · COMPLETED · sponsor: **Sturgill** · enrollment: 8 (actual)

## Conditions studied

- Acute Lung Injury
- Acute Respiratory Distress Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03654352
- **Lead sponsor:** Sturgill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-17
- **Primary completion:** 2021-03-12
- **Final completion:** 2021-03-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654352, "The ASTERS Study: Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome (ARDS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03654352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*